Imiquimod in clinical practice

Journal of the American Academy of Dermatology

Volumn 43, Issue 1 PART II, 2000, Pages

  Edwards, Libby ^a,b  

^a Southeast Vulvar Clinic   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CANTHARIDIN; DICHLOROACETIC ACID; IMIQUIMOD; MESSENGER RNA; PODOPHYLLIN; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID; VIRUS DNA;

ANTIVIRAL ACTIVITY; CAUTERIZATION; CLINICAL TRIAL; CONDYLOMA; CRYOTHERAPY; CURETTAGE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; HUMAN; INFLAMMATION; LASER SURGERY; MOLLUSCUM CONTAGIOSUM; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; VIRUS INFECTION;

AMINOQUINOLINES; CONDYLOMATA ACUMINATA; HUMANS; INTERFERON INDUCERS; MOLLUSCUM CONTAGIOSUM; PAPILLOMAVIRIDAE; TUMOR VIRUS INFECTIONS;

EID: 0033933869     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.107806     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. 1993 sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1993;42(RR14):1-102.
2. Eron LJ, Judson F, Tucker S, Prawer S, Mills J, Murphy K, et al. Interferon therapy for condylomata acuminata. N Engl J Med 1986;315:1059-64.
3. Friedman-Kien AE, Eron LJ, Conant M, Growdon W, Badiak H, Bradstreet PW, et al. Natural interferon alfa for treatment of condylomata acuminata. JAMA 1988;259:533-8.
4. Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998;134:25-30.
5. Data on file, 3M Pharmaceuticals.
6. Beutner KR, Tyring SK, Trofatter KF Jr, Douglas JM Jr, Spruance S, Owens ML, et al. Imiquimod, a patient-applied immune-response modifier for treatment of external warts. Antimicrob Agents Chemother 1998;42:789-94.
7. Tyring SK, Arany I, Stanley MA, Tomai MA, Miller RL, Smith MH, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998;178:551-5.
8. Syed TA, Ahmadpour OA, Ahmad SA, Ahmad SH. Management of female genital warts with an analog of imiquimod 2% cream: a randomized, double-blind, placebo-controlled study. J Dermatol 1998;25:429-33.
9. 2-laser ablation: the influence of the cyclic low-dose therapy regimen - results of a multicentre double-blind placebo-controlled clinical trial [letter]. Genitourin Med 1996;72:71.
10. Petersen CS, Bjerring P, Larsen J, Blaakaer J, Hagdrup H, From E, et al. Systemic interferon α-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study. Genitourin Med 1991;67:99-102.
11. Strauss MJ, Khanna V, Koenig JD, Downs SM, Goldberg SH, Manyak MJ, et al. The cost of treating genital warts. Int J Dermatol 1996;35:340-8.
12. Langley PC, Tyring SK, Smith MH. The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts. Am J Manag Care 1999;5:69-77.
13. Beutner K, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999;41:1002-7.
14. Smith KJ, Liota E, Yeager J, Menon P. Treatment of molluscum contagiosum with topical imiquimod [abstract 352]. Presented at the Annual Meeting of the American Academy of Dermatology, New Orleans, LA, March 19-24, 1999.
15. Syed TA, Goswami J, Ahmadpour OA, Ahmad SA. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol 1998;25:309-13.